Skip to main content
. 2022 May 21;32(4):582–595. doi: 10.1111/jon.13011

TABLE 1.

Summary of future directions of fMRI studies to improve the identification of biomarkers in major depressive disorder

Future opportunities Benefits
Image acquisition
  • Higher magnetic field strength

  • Multiband imaging

  • Multiecho imaging

  • SNR and BOLD sensitivity increase

  • Less signal dropout

  • Scanning time reduction

Image processing
  • Neural network‐based cleaning methods

  • Improved noise cleaning by:

    • More accurate identification of non‐BOLD independent components

    • Optimized motion regressors

Image analysis
  • Causality in brain activation

  • Functional neurodynamics

  • Identification of depression biotypes

  • More extensive insights on potential functional abnormalities of MDD

  • Address MDD heterogeneity

Note: A summary of future opportunities of functional MRI studies to identify more consistent major depressive disorder biomarkers.

Abbreviations: BOLD, blood‐oxygen‐level dependent; MDD, major depressive disorder; SNR, signal‐to‐noise ratio.